The goal for this project is to develop diagnostic tools, deliver treatments, and ultimately find a cure and prevention for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). OMF has funded 3 ME/CFS Collaborative Research Centers. Ronald W. Davis, PhD, leads the Center at Stanford University, Ronald G. Tompkins, MD, ScD, and Wenzhong Xiao, PhD, co-direct the collaboration at Massachusetts General Hospital (MGH), and Jonas Bergquist, MD, PhD, directs the Center at Uppsala University.
ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) is disrupting the lives of 20+ million people of all ages around the globe. There is no current diagnostic test or effective treatment. Many patients are dismissed by doctors. Patients suffer from debilitating symptoms including post-exertional malaise, unrefreshing sleep, profound fatigue, cognitive impairment, orthostatic intolerance, and pain. 75% of patients are unable to work or attend school full time & 25% are home or bed-bound.
OMF envisions a world where people affected by ME/CFS return to living full, productive lives. The End ME/CFS Project is bringing together world-renowned researchers to share open, collaborative research to understand the disease, identify a diagnostic test and effective treatments, and ultimately, find a cure. Researchers at 3 OMF-funded Collaborative Research Centers (Stanford, Harvard, & Uppsala) are working together with a growing scientific group to find answers quickly.
ME/CFS has similar symptomology to a number of chronic complex diseases. This research into ME/CFS will likely provide a greater understanding and assistance to these related diseases including post treatment Lyme disease, fibromyalgia, and more.
Learn more about The End ME/CFS Project
Learn more about ME/CFS
Learn about OMF's work